The SPAC said it still expects a shareholder vote by year’s end on the $100 milion deal. Read more.
Related Posts
RMG Sets Date on Romeo Merger Vote
If approved, the combined company would have pro forma equity value estimated at $1.33 bilion.
Medicus Sciences Acquisition Negotiates LOI with Anteris Technologies
Anteris Technologies, a medical tech company focused on structural heart components, including heart valves.
Freedom Acquisition I Files for $250M IPO
The new SPAC will target financial services companies and fintechs that demonstrate growth and scalability potential.
European Biotech Acquisition Adds $15M to Oculis Deal
Announced in October, the merger is expected to deliver gross proceeds to Oculis in excess of $200 million (assuming no redemptions).